Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000929638-25-003714·Chen Bihua
Schedule 13G ownership disclosure
MOONLAKE IMMUNOTHERAPEUTICS
Class A Ordinary Shares · CUSIP: 61559X104
Event date: 2025-09-30
- Filing-level shares
- 1,994,173
- Percent of class
- 3.14%
- Chen Bihua
Shares: 1,994,173 · Class: 3.14%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000929638-25-003714
- Form type
- SCHEDULE 13G/A
- Filer
- Chen Bihua
- CIK
- CIK 1599214
- Filed
- Oct 01, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership